A rating of 79 puts Crispr Therapeutics AG (CRSP) near the top of the Healthcare sector according to InvestorsObserver.
Crispr Therapeutics AG's score of 79 means that it ranks higher than 79% of stocks in the sector. In addition, its overall score of 89 ranks it higher than 89% of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Crispr Therapeutics AG Stock Today?
Crispr Therapeutics AG (CRSP) stock is up 1.43% while the S&P 500 has fallen -0.64% as of 2:01 PM on Wednesday, Oct 14. CRSP has risen $1.47 from the previous closing price of $103.06 on volume of 1,491,263 shares. Over the past year the S&P 500 has gained 16.48% while CRSP has risen 175.37%. CRSP earned $0.47 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 223.82.
Click Here to get the full Stock Score Report on Crispr Therapeutics AG (CRSP) Stock.
